Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase

Full text
Author(s):
Ferreira, Adilson Kleber [1] ; Meneguelo, Renato [2] ; Navarro Marques, Fabio Luiz [3] ; Radin, Adriano [3] ; Filho, Otaviano Mendonca R. [4] ; Claro Neto, Salvador [2] ; Chierice, Gilberto Orivaldo [2] ; Maria, Durvanei Augusto [1]
Total Authors: 8
Affiliation:
[1] Butantan Inst, Biochem & Biophys Lab, Sao Paulo - Brazil
[2] Univ Sao Paulo, Dept Chem & Polymers Technol, Sao Carlos, SP - Brazil
[3] Univ Sao Paulo, Fac Med, Dept Radiol, Lab Clin Radioisotopia, Sao Paulo - Brazil
[4] Univ Uberaba, UNIUBE, Uberaba, MG - Brazil
Total Affiliations: 4
Document type: Journal article
Source: BIOMEDICINE & PHARMACOTHERAPY; v. 66, n. 7, p. 541-548, OCT 2012.
Web of Science Citations: 14
Abstract

Phosphoethanolamine (Pho-s) is a compound involved in phospholipid turnover, acting as a substrate for many phospholipids of the cell membranes, especially phosphatidylcholine. We recently reported that synthetic Pho-s has potent effects on a wide variety of tumor cells. To determine if Pho-s has a potential antitumor activity, in this study we evaluated the activity of Pho-s against the B16-F10 melanoma both in vitro and in mice bearing a dorsal tumor. The treatment of B16F10 cells with Pho-s resulted in a dose-dependent inhibition of cell proliferation. At low concentrations, this activity appears to be involved in the arrest of the cell cycle at G2/M, while at high concentrations Pho-s induces apoptosis. In accordance with these results, the loss of mitochondrial potential and increased caspase-3 activity suggest that Phos has dual antitumor effects; i.e. it induces apoptosis at high concentrations and modulates the cell cycle at lower concentrations. In vivo, we evaluated the effect of Pho-s in mice bearing B16-F10 melanoma. The results show that Pho-s reduces the tumoral volume increasing survival rate. Furthermore, the tumor doubling time and tumor delays were substantially reduced when compared with untreated mice. Histological analyses reveal that Pho-s induces changes in cell morphology, typical characteristics of apoptosis, in addition the large areas of necrosis correlating with a reduction of tumor size. The results presented here support the hypothesis that Pho-s has antitumor effects by the induction of apoptosis as well as the inhibition of cell proliferation by arrest at G2/M. Thus, Pho-s can be regarded as a promising agent for the treatment of melanoma. Published by Elsevier Masson SAS. (AU)